Raymond James Financial Portfolio holdings
Raymond James Financial, founded in 1962 by Robert James and headquartered in St. Petersburg, Florida, is a diversified financial services firm managing over $1.5 trillion in client assets as of late 2024, primarily focused on wealth management, investment banking, and brokerage services. Known for its advisor-centric model, the firm supports over 8,900 financial advisors across the U.S., Canada, and the UK, offering personalized financial planning, retirement solutions, and investment products to individuals, small businesses, and institutions. Its investment banking arm specializes in middle-market mergers, acquisitions, and equity offerings, while its Raymond James Bank provides lending and deposit services. With a reputation for a conservative, client-first culture and steady growth—including a notable acquisition of TriState Capital in 2022—Raymond James stands out as a resilient, relationship-driven player in the financial industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$809M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$396M |
| 3 |
Zoetis
ZTS
|
+$278M |
| 4 |
iShares Core MSCI Europe ETF
IEUR
|
+$268M |
| 5 |
Microsoft
MSFT
|
+$202M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$433M |
| 2 |
Medtronic
MDT
|
+$371M |
| 3 |
Bank of America
BAC
|
+$124M |
| 4 |
Corning
GLW
|
+$123M |
| 5 |
Vanguard FTSE Pacific ETF
VPL
|
+$114M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.68% |
| 2 | Financials | 8.02% |
| 3 | Industrials | 7.08% |
| 4 | Healthcare | 6.16% |
| 5 | Consumer Discretionary | 5.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KZIA
5001
Kazia Therapeutics
KZIA
$159M
| $117K | ﹤0.01% |
+15,749
| New | +$110K |
|
5002
RF Industries
RFIL
$139M
| $117K | ﹤0.01% |
+11,300
| New | +$115K |
|
5003
Prothena Corp
PRTA
$450M
| $116K | ﹤0.01% |
11,884
-4,599
| -28% | -$42.1K |
|
5004
Paysafe
PSFE
$375M
| $115K | ﹤0.01% |
16,921
+2,806
| +20% | +$19.9K |
|
|
LPRO
5005
DELISTED
Open Lending Corp
LPRO
| $114K | ﹤0.01% |
91,175
-60,880
| -40% | -$96.3K |
|
|
OGCP
5006
Empire State Realty Series 60
OGCP
| $113K | ﹤0.01% |
21,474
| – | – |
|
5007
SEALSQ Corp
LAES
$573M
| $112K | ﹤0.01% |
42,610
+5,275
| +14% | +$20.6K |
|
5008
374Water
SCWO
$37.6M
| $111K | ﹤0.01% |
39,023
| – | – |
|
5009
Heron Therapeutics
HRTX
$92.9M
| $111K | ﹤0.01% |
138,203
+18,004
| +15% | +$20.9K |
|
5010
Vir Biotechnology
VIR
$1.49B
| $111K | ﹤0.01% |
+12,333
| New | +$98.3K |
|
|
AGNT
5011
AGNT Inc
AGNT
$734M
| $109K | ﹤0.01% |
18,277
+1
| +0% | +$8 |
|
|
SVCO
5012
Silvaco Group
SVCO
$256M
| $109K | ﹤0.01% |
+15,443
| New | +$69.5K |
|
|
PCM
5013
PCM Fund
PCM
$70.1M
| $109K | ﹤0.01% |
19,133
+1,197
| +7% | +$7.14K |
|
5014
Yext
YEXT
$574M
| $109K | ﹤0.01% |
28,332
-20,553
| -42% | -$124K |
|
5015
Omeros
OMER
$959M
| $109K | ﹤0.01% |
10,276
-1,966
| -16% | -$23.2K |
|
5016
Annexon
ANNX
$886M
| $107K | ﹤0.01% |
19,369
-5,500
| -22% | -$31K |
|
5017
DiaMedica Therapeutics
DMAC
$364M
| $107K | ﹤0.01% |
15,791
-10
| -0.1% | -$79 |
|
5018
Cibus
CBUS
$138M
| $107K | ﹤0.01% |
53,800
-4,903
| -8% | -$12.6K |
|
5019
Shoals Technologies Group
SHLS
$1.5B
| $106K | ﹤0.01% |
16,183
-1,306,632
| -99% | -$10.7M |
|
5020
AtaiBeckley Inc
ATAI
$2.68B
| $106K | ﹤0.01% |
29,990
-1,352
| -4% | -$5.09K |
|
|
ANGX
5021
Angel Studios
ANGX
$801M
| $105K | ﹤0.01% |
34,500
-387,516
| -92% | -$1.48M |
|
|
LAR
5022
Lithium Argentina AG
LAR
$1.14B
| $105K | ﹤0.01% |
15,735
-1,094
| -7% | -$7.83K |
|
|
GRFS
5023
Grifois
GRFS
$5.4B
| $105K | ﹤0.01% |
13,104
+1,878
| +17% | +$16.6K |
|
5024
PUT
Bristol-Myers Squibb
BMY
$132B
| $105K | ﹤0.01% |
2,000
| – | – |
|
5025
Sana Biotechnology
SANA
$980M
| $105K | ﹤0.01% |
36,407
-2,866
| -7% | -$11.3K |
|
Similar funds
Raymond James Financial's Q1 2026 Portfolio in Review
As of Q1 2026, Raymond James Financial held 5,490 positions worth $324B, up 0.94% from $321B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Raymond James Financial's Q1 2026 filing shows 349 new, 2,830 increased, 1,948 reduced and 210 closed positions. Its largest new stake was Lazard International Dynamic Equity ETF: 663,484 shares worth $21.1M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $433M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Financials and Industrials.
- Raymond James Financial's largest Q1 2026 buy was Lazard International Dynamic Equity ETF: 663,484 shares worth $21.1M.
- Raymond James Financial added most to Vanguard S&P 500 ETF in Q1 2026, an estimated $809M increase.
- Raymond James Financial's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $433M.
- Raymond James Financial fully exited New Gold Inc in Q1 2026, selling an estimated $19M.
- Raymond James Financial's ten largest holdings make up 21% of its $324B portfolio in Q1 2026.
- Raymond James Financial opened 349 new positions and closed 210 in Q1 2026.
- Raymond James Financial's portfolio value rose 0.94% quarter-over-quarter to $324B.
Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.